Viewing Study NCT02571556


Ignite Creation Date: 2025-12-24 @ 11:15 PM
Ignite Modification Date: 2026-03-01 @ 1:26 PM
Study NCT ID: NCT02571556
Status: COMPLETED
Last Update Posted: 2016-11-30
First Post: 2015-10-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: OPEN-LABEL, MULTI-CENTER, PHASE 1b/2a CLINICAL TRIAL DESIGNED TO EVALUATE THE SAFETY AND EFFICACY OF IONTOPHORETIC DEXAMETHASONE PHOSPHATE OPHTHALMIC SOLUTION IN PATIENTS HAVING UNDERGONE CATARACT SURGERY WITH IMPLANTATION OF A POSTERIOR CHAMBER INTRAOCULAR LENS (IOL)
Sponsor: Eyegate Pharmaceuticals, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: EGP-437-008
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators